National Mammography Quality Assurance Advisory Committee; Amendment of Notice, 56658 [2016-19957]
Download as PDF
56658
Federal Register / Vol. 81, No. 162 / Monday, August 22, 2016 / Notices
asabaliauskas on DSK3SPTVN1PROD with NOTICES
and will select and notify participants
by September 14, 2016. All requests to
make oral presentations must be
received by September 13, 2016. If
selected for presentation, any
presentation materials must be emailed
to David Litwack (see FOR FURTHER
INFORMATION CONTACT) no later than
September 16, 2016, at 5 p.m. No
commercial or promotional material
will be permitted to be presented or
distributed at the public workshop.
FDA is holding this public workshop
to obtain feedback on its recently
released draft guidance documents:
‘‘Use of Public Human Genetic Variant
Databases to Support Clinical Validity
for Next Generation Sequencing-Based
In Vitro Diagnostics’’ and ‘‘Use of
Standards in the Food and Drug
Administration’s Regulatory Oversight
of Next Generation Sequencing-Based In
Vitro Diagnostics Used for Diagnosing
Germline Diseases’’. In order to permit
the widest possible opportunity to
obtain public comment, FDA is
soliciting either electronic or written
comments on all aspects of the public
workshop topics. The deadline for
submitting comments related to this
public workshop is October 6, 2016.
Transcripts: Please be advised that as
soon as a transcript is available, it will
be accessible at https://
www.regulations.gov. It may be viewed
at the Division of Dockets Management
(see ADDRESSES). A transcript will also
be available in either hardcopy or on
CD–ROM, after submission of a
Freedom of Information request. A
transcript will also be available in either
hardcopy or on CD–ROM, after
submission of a Freedom of Information
request. The Freedom of Information
office address is available on the
Agency’s Web site at https://
www.fda.gov. A link to the transcripts
will also be available approximately 45
days after the public workshop on the
Internet at https://www.fda.gov/
MedicalDevices/NewsEvents/
WorkshopsConferences/default.htm.
(Select this public workshop from the
posted events list.)
Dated: August 17, 2016.
Peter Lurie,
Associate Commissioner for Public Health
Strategy and Analysis.
[FR Doc. 2016–19939 Filed 8–19–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
[Docket No. FDA–2016–N–2474]
[Docket No. FDA–2016–N–0001]
National Mammography Quality
Assurance Advisory Committee;
Amendment of Notice
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
AGENCY:
Notice.
The Food and Drug
Administration (FDA) is announcing an
amendment to the notice of meeting of
the National Mammography Quality
Assurance Advisory Committee. This
meeting was announced in the Federal
Register of August 5, 2016. The
amendment is being made to reflect a
change in the ADDRESSES portion of the
document. There are no other changes.
SUMMARY:
S.J.
Anderson, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 1552, Silver Spring,
MD 20993–0002, Sara.Anderson@
fda.hhs.gov, 301–796–6875, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), code MA. Please
call the Information Line for up-to-date
information on this meeting.
FOR FURTHER INFORMATION CONTACT:
In the
Federal Register of August 5, 2016 (81
FR 51918), FDA announced that a
meeting of the National Mammography
Quality Assurance Advisory Committee
would be held on September 15, 2016.
On page 51919, in the first column, in
the ADDRESSES portion: Hilton
Washington, DC/North, Salons A, B, C
and D, 620 Perry Pkwy., Gaithersburg,
MD 20877. The hotel’s telephone
number is 301–977–8900, is changed to
read as follows: Gaithersburg Holiday
Inn—Grand Ballroom, 2 Montgomery
Village Ave., Gaithersburg, MD 20878.
The hotel’s telephone number is 301–
948–8900.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
SUPPLEMENTARY INFORMATION:
Dated: August 17, 2016.
Janice M. Soreth,
Acting Associate Commissioner, Special
Medical Programs.
BILLING CODE 4164–01–P
17:13 Aug 19, 2016
Jkt 238001
PO 00000
Frm 00082
Fmt 4703
Food and Drug Administration,
HHS.
[FR Doc. 2016–19957 Filed 8–19–16; 8:45 am]
VerDate Sep<11>2014
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Reporting
Associated With Designated New
Animal Drugs for Minor Use and Minor
Species
Sfmt 4703
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the reporting associated with
designation under the Minor Use and
Minor Species Animal Health Act of
2004.
SUMMARY:
Submit either electronic or
written comments on the collection of
information by October 21, 2016.
ADDRESSES: You may submit comments
as follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
E:\FR\FM\22AUN1.SGM
22AUN1
Agencies
[Federal Register Volume 81, Number 162 (Monday, August 22, 2016)]
[Notices]
[Page 56658]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19957]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2016-N-0001]
National Mammography Quality Assurance Advisory Committee;
Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
amendment to the notice of meeting of the National Mammography Quality
Assurance Advisory Committee. This meeting was announced in the Federal
Register of August 5, 2016. The amendment is being made to reflect a
change in the ADDRESSES portion of the document. There are no other
changes.
FOR FURTHER INFORMATION CONTACT: S.J. Anderson, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 1552, Silver Spring, MD 20993-0002,
Sara.Anderson@fda.hhs.gov, 301-796-6875, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area), code MA. Please call the Information Line for up-to-date
information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of August 5, 2016
(81 FR 51918), FDA announced that a meeting of the National Mammography
Quality Assurance Advisory Committee would be held on September 15,
2016. On page 51919, in the first column, in the ADDRESSES portion:
Hilton Washington, DC/North, Salons A, B, C and D, 620 Perry Pkwy.,
Gaithersburg, MD 20877. The hotel's telephone number is 301-977-8900,
is changed to read as follows: Gaithersburg Holiday Inn--Grand
Ballroom, 2 Montgomery Village Ave., Gaithersburg, MD 20878. The
hotel's telephone number is 301-948-8900.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: August 17, 2016.
Janice M. Soreth,
Acting Associate Commissioner, Special Medical Programs.
[FR Doc. 2016-19957 Filed 8-19-16; 8:45 am]
BILLING CODE 4164-01-P